Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flaherty Financial News is a specialized media and financial news organization focused on the biotechnology and life sciences sectors. Led by veteran financial journalist Robert Flaherty, the company provides in-depth analysis, newsletters, and reports such as 'The Flaherty Report,' which tracks emerging biotech companies and clinical trial developments. The firm serves investors and industry professionals by distilling complex scientific data into actionable financial insights. It is primarily known for its coverage of small-cap and micro-cap healthcare stocks and its presence at major industry conferences. The organization plays a role in the biotech ecosystem by providing visibility to early-stage companies and helping investors navigate the volatility of the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flaherty Financial News.